By lowering blood sugar, the GLP-1 drugs can help protect the kidneys from this detrimental effect, which may delay or prevent kidney disease and kidney failure
About this article Cite this article Manna, I., Bandyopadhyay, M
This study also demonstrated that the GLP-1R agonist liraglutide caused a shift in energy metabolism from carbohydrates to lipids, which could potentially be explained by GLP-1R activation inducing BAT thermogenesis and increasing hepatocyte and skeletal muscle cell glycogenesis, sparing glycogen
Exendinphe1 had a progressively larger effect on blood glucose lowering 4 and 8 h after dosing compared to exendin4 despite identical pharmacokinetics, suggesting the effects of minimised GLP1 receptor desensitisation demonstrated in vitro are also seen in vivo
Used in Russian medical research for anxiety reduction and cognitive support